G-CSF polypeptides and uses thereof

Details G-CSF polypeptides and uses thereof G-CSF polypeptides and uses thereof

2011-01-04

2011-01-04

Shafer, Shulamith H. (Department: 1647)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S320100, C435S325000, C536S023400, C536S023500

Reexamination Certificate

active

07863016

ABSTRACT:
The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.

REFERENCES:
patent: 5399345 (1995-03-01), Schumacher et al.
patent: 5532341 (1996-07-01), Welte et al.
patent: 7141547 (2006-11-01), Rosen et al.
patent: 2004/0247562 (2004-12-01), Lee et al.
patent: 0 243 153 (1987-04-01), None
patent: 1 233 065 (2002-08-01), None
patent: WO 97/12977 (1997-04-01), None
patent: WO 00/40728 (2000-07-01), None
patent: WO 03/018612 (2003-03-01), None
patent: WO 03/027288 (2003-04-01), None
patent: WO 2005/121174 (2005-12-01), None
Dunham et al. 2001. Cytokine 14:347-351.
Layton et al 2006. Frontiers in Bioscience 11:3181.
Nagata S. et al. “The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor”,The EMBO Journal, 1986, pp. 575-581, vol. 5, No. 3.
Souza, L.M. et al. “Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells”,Science, Apr. 4, 1986, pp. 61-65, vol. 232, No. 4746.
Metcalf, D. “The Granulocyte-Macrophage Colony Stimulating Factors”,Cell, Nov. 1985, pp. 5-6, vol. 43, No. 1.
Swissprot database P09919, Jul. 1, 1989.
Sorg, R. et al. “Rapid and Sensitive mRNA Phenotyping for Interleukins (IL-1 to IL-6) and Colony-stimulating Factors (G-CSF, M-CSF, and GM-CSF) by Reverse Transcription and Subsequent Polymerase Chain Reaction”,Exp. Hematol., 1991, pp. 882-887, vol. 19, No. 9.
Cusi, M.G. et al. “Harlequin granulocyte-colony stimulating factor interleukin 6 molecules with bifunctional and antagonistic activities”,Immunotechnology, Jan. 6, 1997, pp. 61-69, vol. 3, No. 1.
Sarkar, C.A. et al. “Parsing the Effects of Binding, Signaling, and Trafficking on the Mitogenic Potencies of Granulocyte Colony-Stimulating Factor Analogues”,Biotechnol. Prog., May-Jun. 2003, pp. 955-964, vol. 19, No. 3.
Hübel, K. et al. “Clinical applications of granulocyte colony-stimulating factor: an update and summary”,Ann Hematol., Mar. 6, 2003, pp. 207-213, vol. 82, No. 4.
Gersting, J.A. et al. “Messenger RNA Expression of Granulocyte Colony-Stimulating Factor Receptor Isoforms in the Fetus”,Biology of the Neonate, 2003, pp. 191-196, vol. 83, No. 3.
Hill, C.P. et al. “The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors”,Proc. Natl. Acad. Sci. USA, Jun. 1993, pp. 5167-5171, vol. 90.
Seto, Y. et al. “Chromosomal Gene Organization of the Human Granulocyte Colony-Stimulating Factor Receptor”,The Journal of Immunology, Jan. 1, 1992, pp. 259-266, vol. 148, No. 1.

Affiliated with

Also associated with

Rating

G-CSF polypeptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with G-CSF polypeptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and G-CSF polypeptides and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2728001